Mission Statement

The Division of Pharmacognosy carries out research in pharmaceutical sciences focused on natural products from medicinal plants and microorganisms. Major tasks are the discovery of new biologically active compounds from natural sources and the characterization of their molecular mode of action contributing to a better understanding of the interaction of natural products and complex cellular systems. Our aim is pharmaceutical lead and target identification, the quality improvement of herbal medicinal products as well as the sustainable production of natural products by biotechnological approaches.

20.10.2022
 

A new FWF project (ESPRIT) entitled "The Bog Bilberry Enigma" has been granted to Zuzana Vaneková (PI) and Judith M. Rollinger (mentor). It will investigate the alleged toxicity of bog bilberry (Vaccinium uliginosum L.) fruits using complex phytochemical, analytical and toxicological methods. Zuzana Vaneková has therefore joined the Phytochemistry and Biodiscovery Lab as a Postdoc researcher.

13.10.2022
 

On October 13th Mag. Thomas Göls defended his PhD thesis entitled „Balm of Norway spruce (Picea abies) as wound healing agent – Isolation, identification and analysis of main constituents and their pro-migratory effect on keratinocytes“. Well done and congratulations Thomas! We wish you all the best for your future career.

10.10.2022
 

Department Meeting

10.10.2022 - 26.01.2023

01.10.2022
 

Ammar Tahir (Pharmaceutical Sciences) and Karl-Heinz Wagner (Nutritional Sciences) have been granted an interdisciplinary research project entitled "Lipidomics and Metabolomics Profile Alteration of Elderly People after Vitamin D Supplementation and Strength Training".

03.08.2022
 

On August 3rd, Julia defended her PhD thesis with the title “Analytical advances to understand the therapeutic potential of natural products in low respiratory tract infections” with great success. Congratulations and all the best for your future, Julia!

22.07.2022
 

On 22.07.2022, Mirta Resetar successfully defended her PhD thesis “Characterization of LRK071, a structural analog of the natural product honokiol, as a novel RXR agonist”. Congratulations!